BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19186057)

  • 41. Water-soluble prodrug of antimicrotubule agent plinabulin: effective strategy with click chemistry.
    Yakushiji F; Tanaka H; Muguruma K; Iwahashi T; Yamazaki Y; Hayashi Y
    Chemistry; 2011 Nov; 17(45):12587-90. PubMed ID: 21956869
    [No Abstract]   [Full Text] [Related]  

  • 42. Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study.
    Hamada Y; Matsumoto H; Yamaguchi S; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem; 2004 Jan; 12(1):159-70. PubMed ID: 14697781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).
    Leu YL; Roffler SR; Chern JW
    J Med Chem; 1999 Sep; 42(18):3623-8. PubMed ID: 10479293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
    Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
    J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives.
    Shi DF; Bradshaw TD; Chua MS; Westwell AD; Stevens MF
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1093-5. PubMed ID: 11327598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability.
    Richard DJ; Verheijen JC; Curran K; Kaplan J; Toral-Barza L; Hollander I; Lucas J; Yu K; Zask A
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6830-5. PubMed ID: 19896845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT.
    Kamal A; Tekumalla V; Krishnan A; Pal-Bhadra M; Bhadra U
    ChemMedChem; 2008 May; 3(5):794-802. PubMed ID: 18247436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
    Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
    J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR; Thornhill A; Melody N; Knight JC
    J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced water-soluble derivative of PC407 as a novel potential COX-2 inhibitor injectable formulation.
    Liu HF; Wan N; Huan ML; Jia YY; Yuan XF; Zhou SY; Zhang BL
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4794-7. PubMed ID: 25248683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
    Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
    Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of amino acid conjugates of (S)-1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one (DW2282) as water soluble anticancer prodrugs.
    Lee KC; Venkateswararao E; Sharma VK; Jung SH
    Eur J Med Chem; 2014 Jun; 80():439-46. PubMed ID: 24796884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor.
    Suzuki T; Hisakawa S; Itoh Y; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1558-61. PubMed ID: 17257837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium N-(methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)sulfamate: a water-soluble nimesulide prodrug for parenteral use.
    Rapposelli S; Digiacomo M; Franchi S; Moretti S; Pinza M; Sacerdote P; Balsamo A
    Mol Pharm; 2010 Oct; 7(5):1871-6. PubMed ID: 23282004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043).
    Kadow JF; Ueda Y; Meanwell NA; Connolly TP; Wang T; Chen CP; Yeung KS; Zhu J; Bender JA; Yang Z; Parker D; Lin PF; Colonno RJ; Mathew M; Morgan D; Zheng M; Chien C; Grasela D
    J Med Chem; 2012 Mar; 55(5):2048-56. PubMed ID: 22356441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
    Okada H; Kato M; Koyanagi T; Mizuno K
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs.
    Krise JP; Narisawa S; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):922-7. PubMed ID: 10479355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of the phenylurea moiety in a phosphoinositide 3-kinase (PI3K) inhibitor to improve water solubility and the PK profile by introducing a solubilizing group and ortho substituents.
    Kawada H; Ebiike H; Tsukazaki M; Yamamoto S; Koyama K; Nakamura M; Morikami K; Yoshinari K; Yoshida M; Ogawa K; Shimma N; Tsukuda T; Ohwada J
    Bioorg Med Chem; 2016 Jul; 24(13):2897-2906. PubMed ID: 27189888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.